DE69737191D1 - Anti-entzündlich wirkende zusammensetzung aus ei, verfahren zur isolierung und verwendung - Google Patents

Anti-entzündlich wirkende zusammensetzung aus ei, verfahren zur isolierung und verwendung

Info

Publication number
DE69737191D1
DE69737191D1 DE69737191T DE69737191T DE69737191D1 DE 69737191 D1 DE69737191 D1 DE 69737191D1 DE 69737191 T DE69737191 T DE 69737191T DE 69737191 T DE69737191 T DE 69737191T DE 69737191 D1 DE69737191 D1 DE 69737191D1
Authority
DE
Germany
Prior art keywords
egg
insulation
flammable composition
flammable
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69737191T
Other languages
English (en)
Other versions
DE69737191T2 (de
Inventor
G Fitzpatrick-Mcelligott
G Hunchar
Young-Zoon Lee
R Beck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arkion Life Sciences LLC
Original Assignee
Arkion Life Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arkion Life Sciences LLC filed Critical Arkion Life Sciences LLC
Publication of DE69737191D1 publication Critical patent/DE69737191D1/de
Application granted granted Critical
Publication of DE69737191T2 publication Critical patent/DE69737191T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
DE69737191T 1996-03-26 1997-03-19 Entzündungshemmende Zusammensetzung aus Ei, Verfahren zur Isolierung und Verwendung Expired - Fee Related DE69737191T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1409796P 1996-03-26 1996-03-26
US14097P 1996-03-26
US81418797A 1997-03-10 1997-03-10
US814187 1997-03-10
PCT/US1997/004328 WO1997035595A1 (en) 1996-03-26 1997-03-19 Egg anti-inflammatory composition, method of isolation and use

Publications (2)

Publication Number Publication Date
DE69737191D1 true DE69737191D1 (de) 2007-02-15
DE69737191T2 DE69737191T2 (de) 2007-11-08

Family

ID=26685654

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69737191T Expired - Fee Related DE69737191T2 (de) 1996-03-26 1997-03-19 Entzündungshemmende Zusammensetzung aus Ei, Verfahren zur Isolierung und Verwendung

Country Status (10)

Country Link
EP (1) EP0904090B1 (de)
JP (1) JP4316012B2 (de)
KR (1) KR20000004990A (de)
CN (1) CN1178671C (de)
AU (1) AU2332997A (de)
CA (1) CA2249448C (de)
DE (1) DE69737191T2 (de)
HK (1) HK1022623A1 (de)
NZ (1) NZ504132A (de)
WO (1) WO1997035595A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999036077A1 (en) * 1998-01-19 1999-07-22 Dcv, Inc. Composition and method for treatment and prevention of arthritis and/or autoimmune diseases
WO2000043019A2 (en) * 1999-01-19 2000-07-27 Dcv Inc Egg anti-inflammatory composition and method of treating and preventing inflammation
CA2384246A1 (en) * 1999-09-14 2001-03-22 Orn Adalsteinsson Glucosamine and egg reducing inflammation
US6706267B1 (en) 1999-09-14 2004-03-16 Arkion Life Sciences Llc Glucosamine and egg for reducing inflammation
EP1214080B1 (de) * 1999-09-14 2003-11-19 Arkion Life Sciences Glukosamin und hyperimmunisiertes ei zur verminderung von entzündungen
KR20000024460A (ko) * 2000-02-15 2000-05-06 황윤식 복합항원체를 이용한 계란복합항체의 생산 및 피부질환치료용 조성물
KR100392566B1 (ko) * 2001-11-13 2003-07-23 주식회사 에그 바이오택 여드름질환에 관한 프로피오니박테리움 아크네스, 스타필로코커스 에피더미디스, 대장균에 대한 항-혼합균 공유 복합특수면역단백질(IgY) 함유 계란생산 및 항-혼합균 공유 복합특수면역단백질(IgY) 제조방법
US9028882B2 (en) 2005-05-02 2015-05-12 4Life Patents, Llc Nutraceutical gels
US10471100B2 (en) 2006-09-29 2019-11-12 4Life Patents, Llc Nanofraction immune modulators, preparations and compositions including the same, and associated methods
AR086437A1 (es) 2011-10-13 2013-12-11 Aixela Juan Cunill Preparado de huevo con propiedades regeneradoras, analgesicas y/o anti-inflamatorias
ITMI20121076A1 (it) 2012-06-20 2013-12-21 Giellepi S P A Composizione per uso locale nel trattamento del danno tissutale
CN104524570A (zh) * 2014-12-14 2015-04-22 郑州后羿制药有限公司 一种鸡新城疫、禽流感二联卵黄抗体口服液及其制备方法
BR102015020632A2 (pt) * 2015-08-26 2017-03-01 Da Silva Bastos Cesar sistema e processo de obtenção e gestão de volume e con-centração de sanitizante otimizado para a aplicação no procedimento de desinfeção de um módulo aplicador de substâncias in ovo tendo como paradigma a informação do tamanho médio dos ovos férteis vacinados e ou alimentados
WO2018148734A1 (en) 2017-02-13 2018-08-16 The United States Of America, As Represented By The Secretary Of Agriculture Hyperimmunized egg product for treatment of necrotic enteritis in poultry
CN110433176A (zh) * 2019-08-01 2019-11-12 新疆农业大学 蛋清在制备预防奶牛乳房炎抑菌药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5215746A (en) * 1982-06-03 1993-06-01 Stolle Research And Development Corporation Anti-cholesterolemic egg, vaccine and method for production, and use
JPH0499728A (ja) * 1990-08-20 1992-03-31 Nippon Nousan Kogyo Kk 抗炎症作用を有する組成物
JPH07126166A (ja) * 1993-10-29 1995-05-16 Sagami Chem Res Center ホスホリパ−ゼａ２阻害剤
WO1996002255A1 (fr) * 1994-07-15 1996-02-01 Taiyo Kagaku Co., Ltd. Composition medicamenteuse contenant un derive d'acide sialique
JPH0899988A (ja) * 1994-09-29 1996-04-16 Takehiko Yamamoto シアル酸類含有オリゴ糖の製造法

Also Published As

Publication number Publication date
EP0904090A1 (de) 1999-03-31
HK1022623A1 (en) 2000-08-18
CA2249448A1 (en) 1997-10-02
JP2001526629A (ja) 2001-12-18
JP4316012B2 (ja) 2009-08-19
CA2249448C (en) 2003-10-28
NZ504132A (en) 2002-03-28
CN1178671C (zh) 2004-12-08
AU2332997A (en) 1997-10-17
EP0904090B1 (de) 2007-01-03
WO1997035595A1 (en) 1997-10-02
CN1226830A (zh) 1999-08-25
KR20000004990A (ko) 2000-01-25
DE69737191T2 (de) 2007-11-08

Similar Documents

Publication Publication Date Title
DE69810162T2 (de) Feuerschutzmaterial mit niedriger dichte und verfahren zur herstellung
DE69519235D1 (de) Hämorrhoidenzusammensetzungen und verfahren zur verwendung
DE69726788D1 (de) Aluminiumhydroxid, Verfahren zur Herstellung und Verwendung davon
DE59905323D1 (de) Verfahren zur herstellung von methylendi(phenylamin) und methylendi (phenylisocyanat)
DE69608313T2 (de) Druckempfindliche tintensysteme und verfahren zur verwendung
DE69703048D1 (de) Glaszusammensetzung, verfahren und verwendung
DE69715661D1 (de) Verfahren und anlage zur herstellung von methanol
DE69924415D1 (de) Heizelement und Verfahren zu seiner Herstellung
DE69737191D1 (de) Anti-entzündlich wirkende zusammensetzung aus ei, verfahren zur isolierung und verwendung
DE69901178T2 (de) Nichtgesinterte elektrode und verfahren zur herstellung
DE69733137D1 (de) Inhibitoren von picornavirus 3c protease und verfahren zur herstellung und verwendung
DE59913665D1 (de) Verfahren zur katalytischen herstellung von substituierten bipyridylderivaten
DE69736286D1 (de) Verfahren zur herstellung und transformation von manioka protoplasten
DE69707607T2 (de) Enzymbehandeltes Hesperidin, Verfahren zur Herstellung und Verfahren zur Verwendung von enzymbehandeltem Hesperidin
DE69709962T2 (de) Absorbent für metallionen und verfahren zur herstellung und verwendung
DE59810658D1 (de) Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung desselben
DE69608424T2 (de) Schichtzusammensetzung für glasfasern, verwendungsverfahren und produkte daraus
ATE234295T1 (de) Amorphe benzothiophen, verfahren zur herstellung und verwendung
DE69901161D1 (de) Verfahren zur herstellung von mit polyazacycloalkanen gepropften kieselsäuregelen und deren verwendung
DE69936465D1 (de) Cellolosetriacetate und verfahren zur herstellung
DE69702638T2 (de) Wärmedämmende keramische Beschichtung und Verfahren zur Herstellung
DE69726765D1 (de) Schallabsorbierendes und wärmedämmendes material, und verfahren zur herstellung desselben
ATE276383T1 (de) Mangan-phosphat- umwandlungsbeschichtungzusammensetzung und verfahren zur verwendung bei mässigen temperaturen
DE69626299D1 (de) Halbleiteranordnung und verfahren zur herstellung
DE69704751T2 (de) Keramisches poröses Verbundmaterial und Verfahren zu seiner Herstellung

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee